Literature DB >> 3985927

Nifedipine limits infarct size for 24 hours in closed chest coronary embolized dogs.

S Yoshida, J M Downey, F R Friedman, D E Chambers, D J Hearse, D M Yellon.   

Abstract

We studied the ability of nifedipine, a calcium antagonist, to limit infarct size in the closed chest, coronary embolized dog. Immediately after embolization 141Ce labelled microspheres were administered into the left ventricle. Myocardium not receiving microspheres was considered to be the region at risk. The nifedipine group (10 dogs) received a bolus (16 micrograms/kg i.v. over 8 minutes as a loading dose) followed by continuous infusion (1,000 micrograms/24 hours) 10 min after embolization. The control group (9 dogs) received an equal volume of saline. Twenty-four hours after embolization the dogs were sacrificed, the heart sectioned into 4-mm slices and the slices were stained with tetrazolium to reveal the infarct. The region at risk was determined by autoradiography of the microspheres in the heart slices. Infarct and risk zone volume were determined by planimetric methods. The nifedipine group had a significantly smaller infarct volume to risk zone volume ratio than the control group (38.7 +/- 4.7% vs. 79.5 +/- 4.3%, p less than 0.001). We conclude that nifedipine produces a sustained limitation of infarct size following permanent occlusion of a dog's coronary artery.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3985927     DOI: 10.1007/bf01906746

Source DB:  PubMed          Journal:  Basic Res Cardiol        ISSN: 0300-8428            Impact factor:   17.165


  28 in total

1.  Myocardial changes associated with cardiogenic shock.

Authors:  D L Page; J B Caulfield; J A Kastor; R W DeSanctis; C A Sanders
Journal:  N Engl J Med       Date:  1971-07-15       Impact factor: 91.245

2.  Apparent improvement in canine collateral myocardial blood flow during vasodilation depends on criteria used to identify ischemic myocardium.

Authors:  R E Patterson; E S Kirk
Journal:  Circ Res       Date:  1980-07       Impact factor: 17.367

3.  Infarct size reduction by propranolol before and after coronary ligation in dogs.

Authors:  M M Rasmussen; K A Reimer; R A Kloner; R B Jennings
Journal:  Circulation       Date:  1977-11       Impact factor: 29.690

4.  Exerimental coronary artery occlusion. III. The determinants of collateral blood flow in acute coronary occlusion.

Authors:  W Schaper
Journal:  Basic Res Cardiol       Date:  1978 Nov-Dec       Impact factor: 17.165

5.  Early phase acute myocardial infarct size quantification: validation of the triphenyl tetrazolium chloride tissue enzyme staining technique.

Authors:  M C Fishbein; S Meerbaum; J Rit; U Lando; K Kanmatsuse; J C Mercier; E Corday; W Ganz
Journal:  Am Heart J       Date:  1981-05       Impact factor: 4.749

6.  Effect of the calcium antagonist verapamil on necrosis following temporary coronary artery occlusion in dogs.

Authors:  K A Reimer; J E Lowe; R B Jennings
Journal:  Circulation       Date:  1977-04       Impact factor: 29.690

7.  Enzymatic indices of myocardial necrosis: influence on short- and long-term prognosis after myocardial infarction.

Authors:  P L Thompson; E E Fletcher; V Katavatis
Journal:  Circulation       Date:  1979-01       Impact factor: 29.690

8.  Effects of nifedipine on myocardial perfusion and ischemic injury in dogs.

Authors:  P D Henry; R Shuchleib; L J Borda; R Roberts; J R Williamson; B E Sobel
Journal:  Circ Res       Date:  1978-09       Impact factor: 17.367

9.  Acute hemodynamic effects of nifedipine in patients with ischemic heart disease.

Authors:  P A Majid; J De Jong
Journal:  Circulation       Date:  1982-06       Impact factor: 29.690

10.  Failure of nifedipine therapy to reduce myocardial infarct size in the baboon.

Authors:  G G Geary; G T Smith; G T Suehiro; J J McNamara
Journal:  Am J Cardiol       Date:  1982-02-01       Impact factor: 2.778

View more
  4 in total

Review 1.  Secondary prevention after myocardial infarction: effects of beta blocking agents and calcium antagonists.

Authors:  P Depelchin; J Sobolski; M Jottrand; C Flament
Journal:  Cardiovasc Drugs Ther       Date:  1988-05       Impact factor: 3.727

2.  Effect of nifedipine on enzymatically estimated infarct size in the early phase of acute myocardial infarction.

Authors:  L J Walker; G MacKenzie; A A Adgey
Journal:  Br Heart J       Date:  1988-04

3.  Limitation of myocardial necrosis with verapamil during sustained coronary occlusion in the closed-chest dog.

Authors:  J G Kingma; D M Yellon
Journal:  Cardiovasc Drugs Ther       Date:  1988-09       Impact factor: 3.727

4.  Coronary thrombolysis with and without nifedipine in pigs.

Authors:  W J van der Giessen; E Harmsen; P P de Tombe; P G Hugenholtz; P D Verdouw
Journal:  Basic Res Cardiol       Date:  1988 May-Jun       Impact factor: 17.165

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.